Ftse Mib
33.746,66
-1,60%
DAX
17.932,17
-1,10%
S&P 500
5.035,69
-1,57%
NASDAQ Composite
15.657,82
-2,04%
Bitcoin
59.657,48
-1,56%

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NASDAQ PharmaCyte Biotech Inc (PMCB) PharmaCyte Biotech Inc (PMCB) Notizie

PharmaCyte Biotech Inc

PMCB
2,12
0,00 (0,00%)
30 Apr 2024 - Chiuso
Dati in Delay di 15 minuti
Borsa: NASDAQ
Tipo: Azione
Valuta: USD

Ultime notizie

Data Ora Fonte Titolo
14/2/202421:38EDGAR2Form SC 13G - Statement of acquisition of beneficial..
06/2/202415:56EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
15/12/202323:25EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
28/11/202323:06EDGAR2Form 3 - Initial statement of beneficial ownership of..
24/11/202322:00EDGAR2Form 8-K - Current report
22/11/202323:02EDGAR2Form 4 - Statement of changes in beneficial ownership of..
22/11/202323:02EDGAR2Form 4 - Statement of changes in beneficial ownership of..
22/11/202323:01EDGAR2Form 4 - Statement of changes in beneficial ownership of..
22/11/202323:01EDGAR2Form 4 - Statement of changes in beneficial ownership of..
22/11/202323:01EDGAR2Form 4 - Statement of changes in beneficial ownership of..
22/11/202323:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
22/11/202322:00EDGAR2Form SC 13D - General statement of acquisition of beneficial..
15/11/202314:30BWPharmaCyte Biotech Acquires $5 Million Stake in Emerging..
09/11/202323:25EDGAR2Form 8-K - Current report
31/10/202314:15BWPharmaCyte Biotech Provides Corporate Update on..
21/9/202323:04EDGAR2Form S-3/A - Registration statement under Securities Act of..
18/9/202312:04EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
15/9/202323:00EDGAR2Form NT 10-Q - Notification of inability to timely file Form..
12/9/202303:56EDGAR2Form S-3/A - Registration statement under Securities Act of..
07/9/202322:05EDGAR2Form 8-K - Current report
04/8/202322:40EDGAR2Form S-3/A - Registration statement under Securities Act of..
04/8/202322:01EDGAR2Form 8-K - Current report
31/7/202323:18EDGAR2Form 10-K - Annual report [Section 13 and 15(d), not S-K..
31/7/202322:42EDGAR2Form DEF 14A - Other definitive proxy statements
19/7/202316:28EDGAR2Form PRE 14A - Other preliminary proxy statements
15/6/202315:15BWPharmaCyte Biotech Announces Final Results of Tender Offer
11/5/202314:30BWPharmaCyte Biotech Announces Cash Tender Offer for up to..
Apertura: 2,12 Min: 2,12 Max: 2,20
Chiusura: 2,12

La tua Cronologia

NASDAQ
PMCB
PharmaCyte Biotech
Delayed Upgrade Clock

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' CLICCA QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network